Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Did you notice at the bottom of the page that the copyright 2023 address is eroxogel.com and not eroxongel and doesn't seem to exist. Matbe a scam??
SRM72-Don’t think FUM BOD are clever enough to set that site up, they might make some money & that would go against everything they stand for, as I’m starting to think they a not for profit setup!
I wonder how their SP is doing, probably better than the Real Eroxon SP! Anyone know what they trade under May buy a few, bet they release better RNS’s as well! 😂
Very much doubt it,DRM72. the agreement with haleon gives them the right exclusively to commercialise the distribution of eroxon in the us.i assume it it is some form of opportunistic exercise by persons unrelated to fum.
Not sure if this has been discussed but there a site www. eroxongel .com shipping to US costing almost Triple the price. has futura set it up? looks same colours etc as eroxon. Surely they would have registered the Domain Name
Yes, a plausible hypothesis.
Puzzling aspect is that considering the volumes as a ratio of market Cap, this would be just tinkering.
The SP movement in relation to sell/buys volumes, appear to be disproportionate and deliberate.
Could be Lombard doing a rinse and repeat
That sounds like quite a possibility. In which case we’ll just have to slug it out till he/they have finished their mission
Having reflected upon recent posts I have changed my mind about what’s going on here.It is truly perverse that following every new positive development the share price goes down.
I now believe that there is a persistent seller who takes advantage of the good news so that they can sell without crashing the share price.
PI’s then panic seeing the share price going down and sell.
As someone has pointed out if a holder has less than 3% of the share capital,they don’t have to report their changing position.It would still take a considerable time to unwind that sort of holding.
If this analysis is nonsense,then it might be that the share price tracks the reviews on the Boots website!
Its not just this share but the market in general is suffering death by a thousand prics both physically and metaphorically.
Could be shenanigans before its bought by Haleon especially as EU wide patent has been granted until 2040.
Bodes well for patents across the globe
I don’t think £20k out of £150mill will cause a drop of 5%. Something strange going on with this share! IMO
£20k sale does not help
...rubbing on some of the magic gel!
Further drop in SP !!!
Is there any medication for helping me keep my chin up?
Co High dumped their shares after they bought in a private placing shortly after the original china deal announcement
They were clearly just punters
There is in my house :) lol!!!
I have been monitoring for a good no of weeks. And the figures I assume now must be a lot of repeat business? Excellent!
Imagine replication worldwide following launches!
After all thats the want. New buyers etc. additional.
Very happy with this as got its own market/niche.
Sales of Eroxon at Boots online has fallen in recent weeks as has sales of Cialis OTC and Viagra connect ( maybe there’s a sex drought 😳)
At the same time a lot more pharmacy type online sites are offering Eroxon some discounting it by 20%
Has anyone here ever used these sites to order stuff and what’s the view if these sites will boost sales sufficiently?
It is all in the RNS no 1014R dated 4th March 2021 if you can make sense of it
Under the original co-high licensing agreement riverwood high growth fund received certain convertible loan note and warrants.i won't recite the precise details of what they did with them,but the last relaible information we had was the RNS of 4/5/21 stating they had reduced their holding from 3.102% to 2.73%, totalling 7m shares. they may well have reduced further since then as the deal fell through and it would be a reasonable assumption to suggest they would sell down further following its failure. it is ,however,merely an assumption and nothing more.as they were below 3% in may 21,we will have had no statements of any dealings below that level. in case you are not clear, co-high was the licensee,but the shares were held by riverwood. both co high and riverwood are in effect owned by atlantis.
Sorry I am not following the analysis re who is selling. I am sure it is me!
Are you saying Co-High hold over 9m shares that they are trying to sell? I am
not aware that they are on the share registrar:please enlighten us. Given the holding that you suggest would be disclosed on the register and any significant sells would be subject to disclosure.
I think the sells are PI’s who think if they make £200 profit on a 4% rise they are the next Warren Buffet!!
Some time ago, I read that Trinity Delta’s modelling for Futura’s shares put a value of 30-40p on a MED3000 patent extension to 2040. Today, after news of the actual extension, the shares inched forward just over one penny.
The good news seeds of consistent operational achievements are falling on a fairly barren investor ground. Rather than producing the high yields we had been led to expect, and rationally ought to expect, the seeds are currently producing very low, and even zero, yields in terms of pushing the share price up. We are left scratching our heads for answers.
Over the past few months, the good news seeds have had to contend with a determined seller. I thought it might have been Lombard, but now the China / SE Asia agreement with Co-High has been terminated, the seller might be the latter. Its 9.8 million shares would not be easy to get rid off when annual daily turnover in Futura shares is vastly lower.
Price action does have a momentum element to it, so the fact that there’s been so much selling, with the shares down over 20p from their peak on news of the Haleon deal, has probably made some would-be buyers cautious. Ditto, James Barder’s recent uber-conservative musings. Ditto, many investors are still unaware of the sales volumes underpinning the £1.7m revenue in H1, and therefore exactly how much each sales unit will likely contribute to profit. Added to all this, there’s no sight of a desperately needed ‘Lombard-light’ institutional investor or investors to counterbalance the selling / wait and see pressure surrounding the shares. Plus, the SETSqx trading platform for Futura’s shares, with many more price quotes, is containing the volatility of the old days, when with just market makers we could have expected a 20%-30% gap up on opening today, rather than today’s unchanged movement.
After so many false dawns - of good news seeds with low yielding results - I do think that, among the levers Futura’s exec team could consider [also] using is releasing overall monthly sales volumes for Eroxon. Airlines like Ryanair, EasyJet and Wizzair publish monthly passenger volumes; mining companies publish monthly production reports. The publication of monthly Eroxon sales volumes could be time bound, say for the next 3 years, until most geographies have sales volumes. We are realising that six months is way too long to be waiting to learn sales volumes for a novel product. Investors desperately need to know that Eroxon is SELLING, whatever negative reviewers might want people to believe.
The absence of regular actual sales volumes is creating an information vacuum that is contributing to fragile investor confidence, so that good news seeds are left yielding very little in terms of upward share price movement.
I saw and heard this aswell lse1111. Very positive news indeed. There is clearly many dots still being connected with positive news flows anticipated over the next 6 months. I am not a behavioural psychologist. Barder appeared particularly chipper in the Proactive interview given his somewhat languid demeanour.
I sent this email to Trinity researchers today;
I was previously a stockbroker, but now just a private investor. I read your excellent research on Futura Medical, of which I am an investor, and I was wondering if you had seen the recent James Barder interview, and whether this might change your DCF model. Specifically in your note, "On the cusp of MED3000 commercialisation Update | 10 November 2022", you write under Valuation and Financials:
....However, pending visibility on the US terms, and given limited disclosure of precise terms in Europe (which includes multiple revenue layers based on various accounting practices) for simplicity we assume Futura Medical receives payments from partners that are equivalent to a royalty rate of 20% on in-market sales.
However on James Barder on Proactive Futura Medical "on track for a profit in 2025 after strong first half" 2 weeks ago when talking about financials about four minutes in says that margins are around 50%.
I was wondering if you would be looking to update your model in light of this information.